-
841
Prevalence of non-alcoholic fatty liver disease at obesity and its interrelation with cardio-vascular disease and 2nd type diabetes mellitus risk factors
Published 2012-04-01“…To estimate prevalence of non-alcoholic fatty liver disease (NAFLD) in patients with obesity and to determine its interrelation with cardiometabolic risk factors of cardio-vascular diseases (CVD) and diabetes mellitus of the 2nd type (type 2 DM).Material and methods. …”
Get full text
Article -
842
-
843
Meta-Analysis of 11 Heterogeneous Studies regarding Dipeptidyl Peptidase 4 Inhibitor Add-On Therapy for Type 2 Diabetes Mellitus Patients Treated with Insulin
Published 2020-01-01“…Several clinical trials have addressed the therapeutic strategy of adding dipeptidyl peptidase 4 (DPP-4) inhibitors to the treatment of type 2 diabetes mellitus (DM) inadequately controlled by insulin therapy. …”
Get full text
Article -
844
The Impact of C-Peptide and Diabetes Mellitus on Coronary Ectasia and Effect of Coronary Ectasia and C-Peptide on Long-Term Outcomes: A Retrospective Cohort Study
Published 2022-01-01“…This study aimed to reveal the impact of C-peptide and diabetes mellitus (DM) on CAE and the effect of C-peptide and coronary ectasia on long-term outcomes in patients who underwent coronary angiography. …”
Get full text
Article -
845
-
846
Association of Self-Reported Weight Change and Quality of Life, and Exercise and Weight Management Behaviors Among Adults with Type 2 Diabetes Mellitus: The SHIELD Study
Published 2012-01-01“…This study examined the association between self-reported weight change and quality of life, and exercise and weight management behaviors among individuals with type 2 diabetes mellitus (T2DM). Methods. In the US SHIELD study, respondents reported whether they had lost or gained weight compared with 1 year earlier and completed the SHIELD-WQ-9 quality of life questionnaire as well as provided information on their exercise and weight management behaviors in the past 12 months. …”
Get full text
Article -
847
Relationship between Peripheral Blood miR-181c, miR-101, and Cognitive Impairment in Patients with Diabetes Mellitus Complicated with Acute Stroke
Published 2022-01-01“…To explore the relationship between peripheral blood microRNA-181c (miR-181c), microRNA-101 (miR-101), and cognitive impairment (CI) in patients with diabetes mellitus (DM) complicated with acute stroke (AS). …”
Get full text
Article -
848
Efficacy and Safety of Dapagliflozin versus Liraglutide in Patients with Overweight or Obesity and Type 2 Diabetes Mellitus: A Randomised Controlled Clinical Trial in Tianjin, China
Published 2022-01-01“…We aimed to clarify the efficacy of dapagliflozin versus liraglutide in patients with overweight or obesity and type 2 diabetes mellitus (T2DM) at the beginning of the coronavirus disease 2019 (COVID-19) pandemic. …”
Get full text
Article -
849
-
850
The Mediating Effect of Core Attributes of General Practice between Basic Public Health Service and Self-management Behaviors in Patients with Type 2 Diabetes Mellitus
Published 2025-02-01Subjects: “…diabetes mellitus, type 2|health management|general practice|self-management…”
Get full text
Article -
851
Understanding Epistatic Interactions between Genes Targeted by Non-coding Regulatory Elements in Complex Diseases
Published 2014-12-01Subjects: Get full text
Article -
852
Cecum Volvulus. Presentation of a Case and Literature Review
Published 2023-05-01Subjects: Get full text
Article -
853
Editorial: Innovative approaches to exercise assessment and prescription in non-communicable diseases
Published 2025-01-01Subjects: Get full text
Article -
854
Estimation of Cardiovascular Risk in Patients with Type 2 Diabetes
Published 2015-09-01Subjects: Get full text
Article -
855
Application of NerveCheck Master in the Diagnosis of Diabetic Peripheral Neuropathy
Published 2025-01-01Subjects: “…diabetes mellitus…”
Get full text
Article -
856
A Rare Case of Wolfram Syndrome Presenting With Tuberculous Meningitis: A Case Report
Published 2025-01-01Subjects: Get full text
Article -
857
Corrigendum: Notoginsenoside R1 protects against diabetic cardiomyopathy through activating estrogen receptor α and its downstream signaling
Published 2025-01-01Subjects: “…diabetes mellitus…”
Get full text
Article -
858
Use of Platelet Rich Plasma in the Treatment of Diabetic Foot. Case Report
Published 2024-09-01Subjects: “…diabetes mellitus…”
Get full text
Article -
859
-
860